Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in AdultsMark R. Litzow, Martin S. Tallman, Kathryn G. Roberts et al.|New England Journal of Medicine|2024Cited by 213
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignanciesMatthew S. Davids, Alexey V. Danilov, Danielle M. Brander et al.|Blood Advances|2024Cited by 9